New Challenges in Psoriasis Management

Dear Colleagues,

The development of a multitude of biological drugs (TNF-alfa inhibitors, anti-IL17/23 blockers) and small molecules (e.g., PDE4 inhibitors, TYK2 inhibitors) has led to significant advances in the treatment of psoriasis. These drugs are changing patients’ quality of life and they are also helping clinicians to better understand psoriasis’s pathophysiology; however, data are still limited on the place in therapy of different drugs in each subpopulation of patients, according to comorbidities, disease severity, and previous exposure to other systemic drugs. Furthermore, the search for biomarkers that might help with classification and therapy selection is still ongoing. In this Special Issue, we will focus on the new upcoming challenges in managing psoriasis, with a particular interest in real-world experiences. The final aim of this Special Issue is to explore all of the efficacy and safety data coming from real-life experiences in or already-published literature (reviews are encouraged) on managing psoriasis with different treatment options.

Dr. Mario Valenti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• psoriasis
• psoriatic arthritis
• biologics
• small molecules
• immune-mediated skin diseases